Camden National Bank Bristol Myers Squibb CO Transaction History

Camden National Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $5,210 - $5,825	-90 Reduced 2.31%	3,814 $221,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $7,008 - $7,781	-110 Reduced 2.74%	3,904 $249,000
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $16,427 - $18,632	250 Added 6.64%	4,014 $278,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $29,651 - $35,111	-433 Reduced 10.32%	3,764 $271,000
Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $13 - $7,684	100 Added 2.44%	4,197 $298,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $4,066 - $4,478	-56 Reduced 1.35%	4,097 $315,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $33,814 - $40,546	-550 Reduced 11.69%	4,153 $303,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $13,943 - $16,255	260 Added 5.85%	4,703 $293,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $148,339 - $173,760	-2,507 Reduced 36.07%	4,443 $263,000
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $5,943 - $6,472	-96 Reduced 1.36%	6,950 $464,000
Q1 2021 Aug 04, 2021	BUY	$59.34 - $66.74 $11,274 - $12,680	190 Added 2.77%	7,046 $445,000
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $33,085 - $37,491	-573 Reduced 7.71%	6,856 $426,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $1,370 - $1,602	-25 Reduced 0.34%	7,429 $437,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $232 - $337	-5 Reduced 0.07%	7,454 $415,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $367,057 - $478,793	7,459 New	7,459 $479,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

Stay updated on Camden National Bank with notifications on news.